Engaging expectant parents to receive Tdap vaccination

American Journal of Perinatology

Volumn 31, Issue 5, 2014, Pages 407-412

  Steiner, Brian ^a   Swamy, Geeta K ^a   Walter, Emmanuel B ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cocooning; maternal immunization; pertussis

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE;

ADULT; ARTICLE; DEMOGRAPHY; DIPHTHERIA; DRUG SAFETY; EXPECTANT MOTHER; FEMALE; HUMAN; HUMAN EXPERIMENT; MEDICAL RECORD REVIEW; PERTUSSIS; PREGNANT WOMAN; PRENATAL CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUERPERIUM; TETANUS; VACCINATION; ATTITUDE TO HEALTH; COHORT ANALYSIS; FATHER; MALE; MOTHER; PATIENT ATTITUDE; POSTNATAL CARE; PREGNANCY; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA; WHOOPING COUGH; YOUNG ADULT;

ADULT; ATTITUDE TO HEALTH; COHORT STUDIES; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; FATHERS; FEMALE; HUMANS; MALE; MOTHERS; PATIENT ACCEPTANCE OF HEALTH CARE; POSTNATAL CARE; PREGNANCY; PRENATAL CARE; PROSPECTIVE STUDIES; WHOOPING COUGH; YOUNG ADULT;

EID: 84899936445     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0033-1352483     Document Type: Article

References (34)

1. GüriŚ D., Strebel P. M., Bardenheier B., et al. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis: 1999; 28 6 1230 1237
2. Farizo K. M., Cochi S. L., Zell E. R., Brink E. W., Wassilak S. G., Patriarca P. A. Epidemiological features of pertussis in the United States, 1980-1989. Clin Infect Dis: 1992; 14 3 708 719
3. Cherry J. D. The epidemiology of pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection. Pediatrics: 2005; 115 5 1422 1427
4. Pertussis (Whooping Cough) Outbreaks http://www.cdc.gov/pertussis/ outbreaks/index.html. Accessed February 21, 2013
5. Weber C., Boursaux-Eude C., Coralie G., Caro V., Guiso N. Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years. J Clin Microbiol: 2001; 39 12 4396 4403
6. Jenkinson D. Duration of effectiveness of pertussis vaccine: evidence from a 10. year community study. Br Med J (Clin Res Ed): 1988; 296 6622 612 614
7. Wendelboe A. M., Van Rie A., Salmaso S., Englund J. A. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J: 2005; 24 (5, Suppl): S58 S61
8. Cortese M. M., Baughman A. L., Zhang R., Srivastava P. U., Wallace G. S. Pertussis hospitalizations among infants in the United States, 1993 to 2004. Pediatrics: 2008; 121 3 484 492
9. Tanaka M., Vitek C. R., Pascual F. B., Bisgard K. M., Tate J. E., Murphy T. V. Trends in pertussis among infants in the United States, 1980-1999. JAMA: 2003; 290 22 2968 2975
10. Vitek C. R., Pascual F. B., Baughman A. L., Murphy T. V. Increase in deaths from pertussis among young infants in the United States in the 1990s. Pediatr Infect Dis J: 2003; 22 7 628 634
11. Wendelboe A. M., Njamkepo E., Bourillon A., et al. Infant Pertussis Study Group. Transmission of Bordetella pertussis to young infants. Pediatr Infect Dis J: 2007; 26 4 293 299
12. de Greeff S. C., Mooi F. R., Westerhof A., et al. Pertussis disease burden in the household: how to protect young infants. Clin Infect Dis: 2010; 50 10 1339 1345
13. Bisgard K. M., Pascual F. B., Ehresmann K. R., et al. Infant pertussis: who was the source? Pediatr Infect Dis J: 2004; 23 11 985 989
14. Edwards K. M. Overview of pertussis: focus on epidemiology, sources of infection, and long term protection after infant vaccination. Pediatr Infect Dis J: 2005; 24 (6, Suppl): S104 S108
15. Kretsinger K., Broder K. R., Cortese M. M., et al. Centers for Disease Control and Prevention; Advisory Committee on Immunization Practices; Healthcare Infection Control Practices Advisory Committee. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. MMWR Recomm Rep: 2006; 55 (RR-17): 1 37
16. Centers for Disease Control and Prevention (CDC) Update on overall prevalence of major birth defects-Atlanta, Georgia, 1978-2005. MMWR Morb Mortal Wkly Rep: 2008; 57 1 1 5
17. Castagnini L. A., Healy C. M., Rench M. A., Wootton S. H., Munoz F. M., Baker C. J. Impact of maternal postpartum tetanus and diphtheria toxoids and acellular pertussis immunization on infant pertussis infection. Clin Infect Dis: 2012; 54 1 78 84
18. Centers for Disease Control and Prevention (CDC) Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months - - Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep: 2011; 60 41 1424 1426
19. Bridges C. B., Woods L., Coyne-Beasley T. ACIP Adult Immunization Work Group; Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) recommended immunization schedule for adults aged 19 years and older-United States, 2013. MMWR Surveill Summ: 2013; 62 01 9 19
20. CDC Advisory Committee for Immunization Practices Recommends Tdap Immunization for Pregnant Women http://www.cdc.gov/media/releases/2012/a1024- Tdap-immunization.html. Accessed January 9, 2013
21. Td or Tdap Vaccine - What You Need to Know http://www.cdc.gov/vaccines/ pubs/vis/downloads/vis-td-tdap.pdf. Accessed January 9, 2013
22. Dylag A. M., Shah S. I. Administration of tetanus, diphtheria, and acellular pertussis vaccine to parents of high-risk infants in the neonatal intensive care unit. Pediatrics: 2008; 122 3 e550 e555
23. Walter E. B., Allred N., Rowe-West B., Chmielewski K., Kretsinger K., Dolor R. J. Cocooning infants: Tdap immunization for new parents in the pediatric office. Acad Pediatr: 2009; 9 5 344 347
24. Terrell-Perica S. M., Effler P. V., Houck P. M., Lee L., Crosthwaite G. H. The effect of a combined influenza/pneumococcal immunization reminder letter. Am J Prev Med: 2001; 21 4 256 260
25. Szilagyi P. G., Bordley C., Vann J. C., et al. Effect of patient reminder/recall interventions on immunization rates: A review. JAMA: 2000; 284 14 1820 1827
26. Schrag S. J., Fiore A. E., Gonik B., et al. Vaccination and perinatal infection prevention practices among obstetrician-gynecologists. Obstet Gynecol: 2003; 101 4 704 710
27. Centers for Disease Control and Prevention (CDC) Reasons reported by Medicare beneficiaries for not receiving influenza and pneumococcal vaccinations-United States, 1996. MMWR Morb Mortal Wkly Rep: 1999; 48 39 886 890
28. Daniels N. A., Gouveia S., Null D., Gildengorin G. L., Winston C. A. Acceptance of pneumococcal vaccine under standing orders by race and ethnicity. J Natl Med Assoc: 2006; 98 7 1089 1094
29. Lindley M. C., Wortley P. M., Winston C. A., Bardenheier B. H. The role of attitudes in understanding disparities in adult influenza vaccination. Am J Prev Med: 2006; 31 4 281 285
30. Centers for Disease Control and Prevention (CDC) Adult vaccination coverage-United States, 2010. MMWR Morb Mortal Wkly Rep: 2012; 61 4 66 72
31. Shenson D., Dimartino D., Bolen J., Campbell M., Lu P. J., Singleton J. A. Validation of self-reported pneumococcal vaccination in behavioral risk factor surveillance surveys: experience from the sickness prevention achieved through regional collaboration (SPARC) program. Vaccine: 2005; 23 8 1015 1020
32. Mangtani P., Shah A., Roberts J. A. Validation of influenza and pneumococcal vaccine status in adults based on self-report. Epidemiol Infect: 2007; 135 1 139 143
33. Healthy People 2020: Immunization and Infectious Diseases. http://www.healthypeople.gov/2020/topicsobjectives2020/overview.aspx?topicid=23. Accessed February 21, 2013
34. Stratton K. R., Durch J. S., Lawrence R. S. Vaccines for the 21st Century: A Tool for Decision Making. Washington, DC National Academy Press: 2000